 |
 |
 |
 |
 |
|
|
| Article 1 to 10 out of 15 concerning Frost & Sullivan
|
-
European telemedicine vendors adapt to advances in technology
(07/10/2008)
Telemedicine market will generate $236.0 million by 2014
Although the European telemedicine industry has achieved significant progress, certain technological advances have inadvertently led to new hurdles. These include the greater need for standards and physician acceptance of novel telemedicine ...
-
PACS to change the future of european medical imaging industry
(07/09/2008)
There are significant opportunities in the European picture archiving and communication system (PACS) market for vendors who can provide customised solutions and products that support enhanced workflows.New analysis from Frost & Sullivan, European ...
-
Western European in vitro diagnostics market sustained by new technologies
(07/02/2008)
Market earns $12.65 billion in 2014
Despite issues such as rising R&D costs, poor reimbursement and a decline in prices, the emergence of new technologies is boosting the Western European in vitro diagnostics (IVD) markets. While the introduction of automation and integrated platforms ...
-
Extensive Proteomics Research Strengthens the Uptake for Protein Purification Kits in Europe
(12/05/2007)
The growing need for the production of more proteins within faster timelines is forcing laboratories to look for better expression systems and automated solutions to meet their demands. This increasing need to identify and understand proteins is ...
-
Expiry of PCR Patent Offers Exciting Growth Opportunities for Nucleic Acid Purification and Amplification Technologies
(12/21/2005)
The most widely used nucleic amplification technologies (NATs) are based on polymerase chain reaction (PCR), whose foundational patents expired in the US in March 2005. Patent expiry is expected to unlock considerable market opportunities. Smaller ...
-
Frost & Sullivan Presents 2005 Product Innovation Award to Bruker Daltonics
(12/12/2005)
Bruker Daltonics Inc. announced its selection for the Frost & Sullivan 2005 Product Innovation Award. This award is in recognition of Bruker Daltonics' contributions to a broad array of mass spectrometry technologies and for its commitment to the ...
-
User's Scepticism toward New Technologies Remains a Key Challenge for Automation Software Vendors
(09/09/2005)
Automation software vendors in Europe face a challenging task ahead as they try to convince end users across various industries to replace legacy programmable logic controllers (PLCs) with the more sophisticated software-based systems such as human ...
-
EU Directive on Emissions in Paints and Coatings Strongly Influences the Course of Rheology
(08/12/2005)
Manufacturers Must Produce Environmentally Safe Products to Succeed in the Market
The European market for rheology modifiers in paints is gaining momentum with the gradual recovery of the European economy that began in late 2003 and continued through 2004, ending three years of economic stagnation that preceded.Many rheology ...
-
Early Screening, Innovative Solutions to Underline Importance of ADME/Tox Technologies in Successful Drug Development
(08/10/2005)
Considerable Time, Cost Savings to Accrue from Advanced ADME/Tox Technologies
Typically, new drug approval is a protracted, expensive and complex process. Approximately 90 per cent of clinical candidates fail during the development stage with the estimated costs due to poor absorption, distribution, metabolism, elimination ...
-
New Drug Delivery Techniques Aim to Improve Overall Drug Performance and Efficacy
(03/15/2005)
Quantum leaps made in the field of proteomics, genomics and biotechnology are creating revolutionary therapeutics that require equally impressive drug delivery systems in order for patients to derive optimum benefits. This, coupled with patent ...
 |
|
|
|
|